BioCryst Pharmaceuticals grants 57,100 stock options, 46,400 RSUs to new employees.

BioCryst Pharmaceuticals granted stock options to purchase 57,100 shares and restricted stock units covering 46,400 shares of common stock to four newly-hired employees. The options and RSUs vest in four equal annual installments beginning one year after the grant date, subject to the employees' continued service with the company. Each option has a 10-year term.